Livzon Pharmaceutical Group's total assets for Q4 2025 were ¥24.00B, a decrease of -2.21% from the previous quarter. HK:1513 total liabilities were ¥8.20B for the fiscal quarter, a -10.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.